Literature DB >> 15711276

Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases.

B K Kroon1, S Horenblas, A P Lont, P J Tanis, M P W Gallee, O E Nieweg.   

Abstract

PURPOSE: In this retrospective study we compared the clinical outcome of early vs delayed excision of lymph node metastases in patients with penile squamous cell carcinoma.
MATERIALS AND METHODS: A total of 40 patients with a T2-3 penile carcinoma with lymph node metastases were included in this study. All patients initially presented with bilateral impalpable lymph nodes. In 20 patients (50%) metastases were removed when they became clinically apparent during meticulous followup (median interval 6 months, range 1 to 24). There were 20 patients (50%) who underwent resection of inguinal metastases detected on dynamic sentinel node biopsy before they became palpable. The histopathological characteristics of the tumors and lymph nodes were reevaluated.
RESULTS: The 2 populations were similar in terms of patient age, T-stage, pathological tumor grade, vascular invasion and infiltration depth. Disease specific 3-year survival of patients with positive lymph nodes detected during surveillance was 35% and in those who underwent early resection, 84% (log rank p = 0.0017). In multivariate analysis early resection of occult inguinal metastases detected on dynamic sentinel node biopsy was an independent prognostic factor for disease specific survival (p = 0.006).
CONCLUSIONS: Early resection of lymph node metastases in patients with penile carcinoma improves survival.

Entities:  

Mesh:

Year:  2005        PMID: 15711276     DOI: 10.1097/01.ju.0000154565.37397.4d

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  69 in total

Review 1.  Contemporary management of patients with penile cancer and lymph node metastasis.

Authors:  Andrew Leone; Gregory J Diorio; Curtis Pettaway; Viraj Master; Philippe E Spiess
Journal:  Nat Rev Urol       Date:  2017-04-11       Impact factor: 14.432

Review 2.  [The significance of lymphadenectomy in the management of penile cancer].

Authors:  M Angerer-Shpilenya; G Jakse
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

Review 3.  Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer.

Authors:  Ben Hughes; Joost Leijte; Majid Shabbir; Nick Watkin; Simon Horenblas
Journal:  World J Urol       Date:  2008-07-02       Impact factor: 4.226

4.  Feasibility of performing dynamic sentinel lymph node biopsy as a delayed procedure in penile cancer.

Authors:  Savvas Omorphos; Zia Saad; Manit Arya; Alex Freeman; Peter Malone; Raj Nigam; Jamshed Bomanji; Asif Muneer
Journal:  World J Urol       Date:  2015-06-10       Impact factor: 4.226

5.  What next? Managing lymph nodes in men with penile cancer.

Authors:  Michael Leveridge; D Robert Siemens; Christopher Morash
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

Review 6.  [Penile cancer--aftercare with results. How much is necessary?].

Authors:  R Paul; H van Randenborgh; S Schöler; F May; R Hartung
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

7.  Penile cancer: Optimal management of T1G2 penile cancer remains unclear.

Authors:  Alcides Chaux; Antonio L Cubilla
Journal:  Nat Rev Urol       Date:  2012-12-11       Impact factor: 14.432

Review 8.  How accurate are present risk group assignment tools in penile cancer?

Authors:  Vincenzo Ficarra; G Novara; R Boscolo-Berto; W Artibani; M W Kattan
Journal:  World J Urol       Date:  2008-06-17       Impact factor: 4.226

9.  The impact of Improving Outcomes Guidance on the management and outcomes of patients with carcinoma of the penis.

Authors:  Andrew C Bayles; Krishna K Sethia
Journal:  Ann R Coll Surg Engl       Date:  2010-01       Impact factor: 1.891

10.  Extra-anatomical transobturator bypass graft for femoral artery involvement by metastatic carcinoma of the penis: report of five patients.

Authors:  Ubirajara Ferreira; Leonardo Oliveira Reis; Lia Yumi Ikari; Walter da Silva; Wagner Eduardo Matheus; Fernandes Denardi; Rafael Mamprim Stopiglia; Fábio Husseman Menezes
Journal:  World J Urol       Date:  2008-06-26       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.